Pneumonia due to viral and atypical organisms and their sequelae
Identifieur interne : 001529 ( Istex/Corpus ); précédent : 001528; suivant : 001530Pneumonia due to viral and atypical organisms and their sequelae
Auteurs : Alan SmythSource :
- British Medical Bulletin [ 0007-1420 ] ; 2002.
Abstract
Most children presenting with pneumonia in the industrialised world will have a viral or ‘atypical’ organism. The clinical features of these ‘atypical’ pneumonias may be indistinguishable from bacterial pneumonia. New diagnostic techniques such as the polymerase chain reaction may help in diagnosis and choice of treatment, where appropriate. The pathological and clinical features of infection with each agent are discussed, together with their sequelae.
Url:
DOI: 10.1093/bmb/61.1.247
Links to Exploration step
ISTEX:D1760D2B4DDDD007126547C486024CAD3BD7F5FFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pneumonia due to viral and atypical organisms and their sequelae</title><author wicri:is="90%"><name sortKey="Smyth, Alan" sort="Smyth, Alan" uniqKey="Smyth A" first="Alan" last="Smyth">Alan Smyth</name><affiliation><mods:affiliation>Department of Paediatric Respiratory Medicine, Nottingham City Hospital and Department of Child Health, University of Nottingham, Nottingham, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D1760D2B4DDDD007126547C486024CAD3BD7F5FF</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1093/bmb/61.1.247</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-NK88TQ8T-7/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001529</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001529</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pneumonia due to viral and atypical organisms and their sequelae</title><author wicri:is="90%"><name sortKey="Smyth, Alan" sort="Smyth, Alan" uniqKey="Smyth A" first="Alan" last="Smyth">Alan Smyth</name><affiliation><mods:affiliation>Department of Paediatric Respiratory Medicine, Nottingham City Hospital and Department of Child Health, University of Nottingham, Nottingham, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Medical Bulletin</title><title level="j" type="issue">Childhood respiratory infections</title><title level="j" type="abbrev">Br Med Bull</title><idno type="ISSN">0007-1420</idno><idno type="eISSN">1471-8391</idno><imprint><publisher>Oxford University Press</publisher><date when="2002-03">2002</date><biblScope unit="vol">61</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="247">247</biblScope><biblScope unit="page" to="262">262</biblScope></imprint><idno type="ISSN">0007-1420</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1420</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Most children presenting with pneumonia in the industrialised world will have a viral or ‘atypical’ organism. The clinical features of these ‘atypical’ pneumonias may be indistinguishable from bacterial pneumonia. New diagnostic techniques such as the polymerase chain reaction may help in diagnosis and choice of treatment, where appropriate. The pathological and clinical features of infection with each agent are discussed, together with their sequelae.</div></front></TEI><istex><corpusName>oup</corpusName><keywords><teeft><json:string>viral</json:string><json:string>adenovirus</json:string><json:string>rhinovirus</json:string><json:string>pneumoniae</json:string><json:string>mycoplasma</json:string><json:string>pediatr</json:string><json:string>parainfluenza</json:string><json:string>cystic</json:string><json:string>cochrane</json:string><json:string>chlamydia</json:string><json:string>cystic fibrosis</json:string><json:string>pneumonia</json:string><json:string>influenza</json:string><json:string>erythromycin</json:string><json:string>varicella</json:string><json:string>urealyticum</json:string><json:string>immunisation</json:string><json:string>immunofluorescence</json:string><json:string>respiratory secretion</json:string><json:string>pathogen</json:string><json:string>bronchopulmonary</json:string><json:string>british medical bulletin</json:string><json:string>cochrane library</json:string><json:string>host cell</json:string><json:string>bronchopulmonary dysplasia</json:string><json:string>cochrane review</json:string><json:string>atypical</json:string><json:string>asthma</json:string><json:string>incubation period</json:string><json:string>measles</json:string><json:string>bronchiolitis</json:string><json:string>infection</json:string><json:string>antibiotic</json:string><json:string>vaccine</json:string><json:string>virus infection</json:string><json:string>adenovirus infection</json:string><json:string>clinical feature</json:string><json:string>healthy individual</json:string><json:string>serological evidence</json:string><json:string>ureaplasma urealyticum</json:string><json:string>mycoplasma pneumoniae</json:string><json:string>dysplasia</json:string><json:string>pulmonary exacerbation</json:string><json:string>industrialised world</json:string><json:string>parainfluenza virus type</json:string><json:string>chest radiograph</json:string><json:string>rhinovirus infection</json:string><json:string>prospective study</json:string><json:string>healthy adult</json:string><json:string>respiratory tract</json:string><json:string>neuraminidase inhibitor</json:string><json:string>lower respiratory infection</json:string><json:string>clinical excellence</json:string><json:string>obliterative bronchiolitis</json:string><json:string>polymerase chain reaction</json:string><json:string>nasal mucosa</json:string><json:string>chronic lung disease</json:string><json:string>bacterial pneumonia</json:string><json:string>childhood respiratory disease</json:string><json:string>chlamydia pneumoniae</json:string><json:string>atypical pneumonia</json:string><json:string>tissue culture</json:string><json:string>serological</json:string><json:string>transplant</json:string><json:string>nottingham city hospital</json:string><json:string>atypical organism</json:string><json:string>antiviral agent</json:string><json:string>intravenous ribavirin</json:string><json:string>tracheal aspirate</json:string><json:string>conjunctival scraping</json:string><json:string>young child</json:string><json:string>helpful retrospectively</json:string><json:string>respiratory syncytial virus</json:string><json:string>parainfluenza virus</json:string><json:string>legionella pneumophila</json:string><json:string>epithelial cell</json:string><json:string>cause respiratory infection</json:string><json:string>healthy child</json:string><json:string>more likely</json:string><json:string>rapid diagnosis</json:string><json:string>parainfluenza infection</json:string><json:string>electron micrograph</json:string><json:string>congenital heart disease</json:string><json:string>secondary bacterial infection</json:string><json:string>community study</json:string><json:string>respiratory epithelium</json:string><json:string>viral infection</json:string><json:string>large number</json:string><json:string>pediatr pulmonol</json:string><json:string>younger child</json:string><json:string>secondary infection</json:string><json:string>influenza virus</json:string><json:string>nasal secretion</json:string><json:string>serological test</json:string><json:string>viral culture</json:string><json:string>measles immunisation</json:string><json:string>beneficial effect</json:string><json:string>mild symptom</json:string><json:string>antigenic drift</json:string><json:string>pulmonary function</json:string><json:string>complement fixation test</json:string><json:string>severe infection</json:string><json:string>small number</json:string><json:string>parenteral form</json:string><json:string>respiratory infection</json:string><json:string>lower respiratory tract</json:string><json:string>first year</json:string><json:string>complication such</json:string><json:string>radiological appearance</json:string><json:string>parainfluenza virus infection</json:string><json:string>chlamydia trachomatis</json:string><json:string>national institute</json:string><json:string>common cause</json:string><json:string>coronary artery disease</json:string><json:string>british medical bulletin viral pneumonia</json:string><json:string>viral pneumonia</json:string><json:string>first line antibiotic</json:string><json:string>negative sense</json:string><json:string>infectious disease</json:string><json:string>respiratory disease</json:string><json:string>young adult</json:string><json:string>respiratory tract disease</json:string><json:string>preterm infant</json:string><json:string>older child</json:string><json:string>virus</json:string><json:string>respiratory</json:string><json:string>nasal</json:string><json:string>syndrome</json:string></teeft></keywords><author><json:item><name>Alan Smyth</name><affiliations><json:string>Department of Paediatric Respiratory Medicine, Nottingham City Hospital and Department of Child Health, University of Nottingham, Nottingham, UK</json:string></affiliations></json:item></author><arkIstex>ark:/67375/HXZ-NK88TQ8T-7</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>research-article</json:string></originalGenre><abstract>Most children presenting with pneumonia in the industrialised world will have a viral or ‘atypical’ organism. The clinical features of these ‘atypical’ pneumonias may be indistinguishable from bacterial pneumonia. New diagnostic techniques such as the polymerase chain reaction may help in diagnosis and choice of treatment, where appropriate. The pathological and clinical features of infection with each agent are discussed, together with their sequelae.</abstract><qualityIndicators><score>5.768</score><pdfWordCount>5832</pdfWordCount><pdfCharCount>37633</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>16</pdfPageCount><pdfPageSize>595 x 842 pts (A4)</pdfPageSize><pdfWordsPerPage>365</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>64</abstractWordCount><abstractCharCount>456</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Pneumonia due to viral and atypical organisms and their sequelae</title><pmid><json:string>11997310</json:string></pmid><pii><json:string>0007-1420</json:string></pii><genre><json:string>research-article</json:string></genre><host><title>British Medical Bulletin</title><language><json:string>unknown</json:string></language><issn><json:string>0007-1420</json:string></issn><eissn><json:string>1471-8391</json:string></eissn><publisherId><json:string>brimed</json:string></publisherId><volume>61</volume><issue>1</issue><pages><first>247</first><last>262</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1957</json:string><json:string>2002</json:string></date><geogName></geogName><orgName><json:string>UK World</json:string><json:string>University of Nottingham</json:string><json:string>NICE</json:string><json:string>Department of Paediatrics, Nottingham City Hospital, Hucknall Road, Nottingham NG</json:string><json:string>UK, the National Institute for Clinical Excellence</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Netherlands</json:string></persName><placeName><json:string>Southampton</json:string><json:string>UK</json:string><json:string>US</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Clements et al</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/HXZ-NK88TQ8T-7</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - medicine, general & internal</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - general & internal medicine</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2002</publicationDate><copyrightDate>2002</copyrightDate><doi><json:string>10.1093/bmb/61.1.247</json:string></doi><id>D1760D2B4DDDD007126547C486024CAD3BD7F5FF</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-NK88TQ8T-7/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-NK88TQ8T-7/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/HXZ-NK88TQ8T-7/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Pneumonia due to viral and atypical organisms and their sequelae</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Oxford University Press</publisher><date when="2002-03">2002</date><date type="Copyright" when="2002">2002</date></publicationStmt><notesStmt><note type="content-type" source="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main" xml:lang="en">Pneumonia due to viral and atypical organisms and their sequelae</title><title level="a" type="sub">Childhood respiratory infections</title><author xml:id="author-0000"><persName><surname>Smyth</surname><forename type="first">Alan</forename></persName><affiliation><orgName type="department">Department of Paediatric Respiratory Medicine</orgName><address><addrLine>Nottingham City Hospital and Department of Child Health, University of Nottingham, Nottingham, UK</addrLine><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><idno type="istex">D1760D2B4DDDD007126547C486024CAD3BD7F5FF</idno><idno type="ark">ark:/67375/HXZ-NK88TQ8T-7</idno><idno type="other">247</idno><idno type="DOI">10.1093/bmb/61.1.247</idno><idno type="PII">0007-1420</idno></analytic><monogr><title level="j" type="main">British Medical Bulletin</title><title level="j" type="issue">Childhood respiratory infections</title><title level="j" type="abbrev">Br Med Bull</title><idno type="hwp">bmbull</idno><idno type="nlm-ta">Br Med Bull</idno><idno type="publisher-id">brimed</idno><idno type="pISSN">0007-1420</idno><idno type="eISSN">1471-8391</idno><imprint><publisher>Oxford University Press</publisher><date when="2002-03">2002</date><biblScope unit="vol">61</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="247">247</biblScope><biblScope unit="page" to="262">262</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-09"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en"><p>Most children presenting with pneumonia in the industrialised world will have a viral or ‘atypical’ organism. The clinical features of these ‘atypical’ pneumonias may be indistinguishable from bacterial pneumonia. New diagnostic techniques such as the polymerase chain reaction may help in diagnosis and choice of treatment, where appropriate. The pathological and clinical features of infection with each agent are discussed, together with their sequelae.</p></abstract><textClass ana="subject"><keywords scheme="heading"><term>Article</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-09" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-NK88TQ8T-7/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup, element #text not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="US-ASCII"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="hwp">bmbull</journal-id><journal-id journal-id-type="nlm-ta">Br Med Bull</journal-id>
<journal-id journal-id-type="publisher-id">brimed</journal-id><journal-title>British Medical Bulletin</journal-title><abbrev-journal-title abbrev-type="publisher">Br Med Bull</abbrev-journal-title><issn pub-type="ppub">0007-1420</issn><issn pub-type="epub">1471-8391</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="other">247</article-id>
<article-id pub-id-type="doi">10.1093/bmb/61.1.247</article-id><article-id pub-id-type="pii">0007-1420</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Pneumonia due to viral and atypical organisms and their sequelae</article-title><subtitle>Childhood respiratory infections</subtitle></title-group><contrib-group>
<contrib contrib-type="author"><name><surname>Smyth</surname><given-names>Alan</given-names></name>
<xref rid="A1"></xref>
</contrib><aff id="A1">Department of Paediatric Respiratory Medicine, Nottingham City Hospital and Department of Child Health, University of Nottingham, Nottingham, UK</aff></contrib-group><pub-date pub-type="ppub"><month>03</month><year>2002</year></pub-date><volume>61</volume><issue>1</issue><issue-title>Childhood respiratory infections</issue-title><fpage>247</fpage><lpage>262</lpage><permissions><copyright-year>2002</copyright-year></permissions><abstract xml:lang="en">
<p>Most children presenting with pneumonia in the industrialised world will have a viral or ‘atypical’ organism. The clinical features of these ‘atypical’ pneumonias may be indistinguishable from bacterial pneumonia. New diagnostic techniques such as the polymerase chain reaction may help in diagnosis and choice of treatment, where appropriate. The pathological and clinical features of infection with each agent are discussed, together with their sequelae.</p>
</abstract><custom-meta-wrap><custom-meta><meta-name>hwp-legacy-fpage</meta-name><meta-value>247</meta-value></custom-meta><custom-meta><meta-name>hwp-legacy-dochead</meta-name><meta-value>Article</meta-value></custom-meta></custom-meta-wrap></article-meta></front>
</article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Pneumonia due to viral and atypical organisms and their sequelae</title><subTitle>Childhood respiratory infections</subTitle></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Pneumonia due to viral and atypical organisms and their sequelae</title><subTitle>Childhood respiratory infections</subTitle></titleInfo><name type="personal"><namePart type="given">Alan</namePart><namePart type="family">Smyth</namePart><affiliation>Department of Paediatric Respiratory Medicine, Nottingham City Hospital and Department of Child Health, University of Nottingham, Nottingham, UK</affiliation></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>Oxford University Press</publisher><dateIssued encoding="w3cdtf">2002-03</dateIssued><copyrightDate encoding="w3cdtf">2002</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">Most children presenting with pneumonia in the industrialised world will have a viral or ‘atypical’ organism. The clinical features of these ‘atypical’ pneumonias may be indistinguishable from bacterial pneumonia. New diagnostic techniques such as the polymerase chain reaction may help in diagnosis and choice of treatment, where appropriate. The pathological and clinical features of infection with each agent are discussed, together with their sequelae.</abstract><relatedItem type="host"><titleInfo><title>British Medical Bulletin</title></titleInfo><titleInfo type="abbreviated"><title>Br Med Bull</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0007-1420</identifier><identifier type="eISSN">1471-8391</identifier><identifier type="PublisherID">brimed</identifier><identifier type="PublisherID-hwp">bmbull</identifier><identifier type="PublisherID-nlm-ta">Br Med Bull</identifier><part><date>2002</date><detail type="title"><title>Childhood respiratory infections</title></detail><detail type="volume"><caption>vol.</caption><number>61</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>247</start><end>262</end></extent></part></relatedItem><relatedItem type="references" displayLabel="B1"><titleInfo><title>The World Health Report 1995: Bridging the Gaps</title></titleInfo><note>World Health Organization. The World Health Report 1995: Bridging the Gaps. Geneva: WHO, 1995</note></relatedItem><relatedItem type="references" displayLabel="B2"><titleInfo><title>Pediatr Infect Dis</title></titleInfo><note>Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986; 5: 247–52</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>5</number></detail></part></relatedItem><relatedItem type="references" displayLabel="B3"><titleInfo><title>Arch Dis Child</title></titleInfo><note>Clements H, Stephenson T, Gabriel V et al. Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child 2000; 83: 320–4</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>320</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B4"><titleInfo><title>N Engl J Med</title></titleInfo><note>Dowell SF, Kupronis BA, Zell ER, Shay DK. Mortality from pneumonia in children in the United States, 1939 through 1996. N Engl J Med 2000; 342: 1399–407</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>342</number></detail><extent unit="pages"><start>1399</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B5"><titleInfo><title>Z Rechtsmed</title></titleInfo><note>Entrup M, Brinkmann B. Histologic findings in the lung in sudden infant death [German]. Z Rechtsmed 1990; 103: 425–33</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>103</number></detail><extent unit="pages"><start>425</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B6"><titleInfo><title>Arch Dis Child</title></titleInfo><note>Moulin F, Raymond J, Lorrot M et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84: 332–60</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>332</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B7"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Toikka P, Irjala K, Juven T et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19: 598–602</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>598</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B8"><titleInfo><title>Infect Dis Clin North Am</title></titleInfo><note>Cox NJ, Fukuda K. Influenza. Infect Dis Clin North Am 1998; 12: 27–38</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>27</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B9"><titleInfo><title>Am J Epidemiol</title></titleInfo><note>Serfling RE, Sherman IL, Houseworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957–58, 1960 and 1963. Am J Epidemiol 1967; 86: 433–41</note><part><date>1967</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>433</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B10"><titleInfo><title>J Pediatr</title></titleInfo><note>Neuzil KM, Wright PF, Mitchel EF, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000; 137: 856–64</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>856</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B11"><titleInfo><title>Thorax</title></titleInfo><note>Conway SP, Simmonds EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 1992; 47: 112–4</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>112</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B12"><titleInfo><title>Transplant Int</title></titleInfo><note>Faul JL, Akindipe OA, Berry GJ, Theodore J. Influenza pneumonia in a paediatric lung transplant recipient. Transplant Int 2000; 13: 79–81</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>79</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B13"><titleInfo><title>Semin Respir Infect</title></titleInfo><note>Cate TR. Impact of influenza and other community-acquired viruses. Semin Respir Infect 1998; 13: 17–23</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>17</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B14"><titleInfo><title>BMJ</title></titleInfo><note>Fry J. Influenza, 1959: The story of an epidemic. BMJ 1959; 2: 135–47</note><part><date>1959</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>135</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B15"><titleInfo><title>Immunisation against Infectious Disease</title></titleInfo><note>Anon. Immunisation against Infectious Disease. London: HMSO, 1996; 113–20</note></relatedItem><relatedItem type="references" displayLabel="B16"><titleInfo><title>Cochrane Review</title></titleInfo><note>Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software</note></relatedItem><relatedItem type="references" displayLabel="B17"><titleInfo><title>Cochrane Review</title></titleInfo><note>Cates CJ, Jefferson TO, Barra AI, Rowe BH. Vaccines for preventing influenza in people with asthma (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software</note></relatedItem><relatedItem type="references" displayLabel="B18"><titleInfo><title>Cochrane Review</title></titleInfo><note>Tan A, Bhalla P, Smyth R. Vaccines for preventing influenza in people with cystic fibrosis (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software</note></relatedItem><relatedItem type="references" displayLabel="B19"><titleInfo><title>Cochrane Review</title></titleInfo><note>Jefferson T, Demicheli V, Deeks J, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software</note></relatedItem><relatedItem type="references" displayLabel="B20"><titleInfo><title>Guidance on the Use of Zanamivir (Relenza) in the Treatment of Influenza</title></titleInfo><note>National Institute for Clinical Excellence. Guidance on the Use of Zanamivir (Relenza) in the Treatment of Influenza. London: National Institute for Clinical Excellence, 2000</note></relatedItem><relatedItem type="references" displayLabel="B21"><titleInfo><title>Am Rev Respir Dis</title></titleInfo><note>Laraya-Cuasay LR, Deforest A, Huff D, Lischner H, Huang NN. Chronic pulmonary complications of early influenza virus infection in children. Am Rev Respir Dis 1977; 116: 617–25</note><part><date>1977</date><detail type="volume"><caption>vol.</caption><number>116</number></detail><extent unit="pages"><start>617</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B22"><titleInfo><title>Am J Epidemiol</title></titleInfo><note>Brandt CD, Kim HW, Vargosko AJ et al. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol 1969; 90: 484–500</note><part><date>1969</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>484</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B23"><titleInfo><title>Transplantation</title></titleInfo><note>Simsir A, Greenebaum E, Nuovo G, Schulman LL. Late fatal adenovirus pneumonitis in a lung transplant recipient. Transplantation 1998; 65: 592–4</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>592</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B24"><titleInfo><title>J Pediatr</title></titleInfo><note>Aebi C, Headrick CL, McCracken GH et al. Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration. J Pediatr 1997; 130: 612–5</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>130</number></detail><extent unit="pages"><start>612</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B25"><titleInfo><title>Pediatr Infect Dis</title></titleInfo><note>Dagan R, Schwartz RH, Insel RA, Menegus MA. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis 1984; 3: 246–51</note><part><date>1984</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>246</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B26"><titleInfo><title>Pediatr Res</title></titleInfo><note>Couroucli XI, Welty SE, Ramsay PL et al. Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res 2000; 47: 225–32</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>225</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B27"><titleInfo><title>Chest</title></titleInfo><note>Simila S, Linna O, Lanning P, Heikkinen E, Ala-Houhala, M. Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study. Chest 1981; 80: 127–31</note><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>80</number></detail><extent unit="pages"><start>127</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B28"><titleInfo><title>Nat Med</title></titleInfo><note>van den Hoogen BG, de Jong JC, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719–24</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>719</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B29"><titleInfo><title>Am J Dis Child</title></titleInfo><note>Frank Jr JA, Warren RW, Tucker JA, Zeller J, Wilfert CM. Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am J Dis Child 1983; 137: 1172–4</note><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>1172</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B30"><titleInfo><title>Clin Infect Dis</title></titleInfo><note>Lewis VA, Champlin R, Englund J et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996; 23: 1033–7</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>1033</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B31"><titleInfo><title>Pediatr Pulmonol</title></titleInfo><note>Heidemann SM. Clinical characteristics of parainfluenza virus infection in hospitalized children. Pediatr Pulmonol 1992; 13: 86–9</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>86</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B32"><titleInfo><title>Scand J Infect Dis</title></titleInfo><note>Korppi M, Leinonen M, Makela PH, Launiala K. Bacterial involvement in parainfluenza virus infection in children. Scand J Infect Dis 1990; 22: 307–12</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>307</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B33"><titleInfo><title>Clin Infect Dis</title></titleInfo><note>Cobian L, Houston S, Greene J, Sinnott JT. Parainfluenza virus respiratory infection after heart transplantation: successful treatment with ribavirin. Clin Infect Dis 1995; 21: 1040–1</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1040</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B34"><titleInfo><title>Bull World Health Organ</title></titleInfo><note>Murphy BR, Collins PL. Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting. Bull World Health Organ 1997; 75: 307–13</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>307</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B35"><titleInfo><title>Respir Med</title></titleInfo><note>Peramaki E, Salmi I, Kava T, Romppanen T, Hakkarainen T. Unilateral bronchiolitis obliterans organizing pneumonia and bronchoalveolar lavage neutrophilia in a patient with parainfluenza 3 virus infection. Respir Med 1991; 85: 159–61</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>159</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B36"><titleInfo><title>J Virol</title></titleInfo><note>Smith TJ, Olson NH, Cheng RH et al. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J Virol 1993; 67: 1148–58</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><extent unit="pages"><start>1148</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B37"><titleInfo><title>BMJ</title></titleInfo><note>Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995; 310: 1225–9</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>310</number></detail><extent unit="pages"><start>1225</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B38"><titleInfo><title>Am J Respir Crit Care Med</title></titleInfo><note>Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151: 879–86</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>151</number></detail><extent unit="pages"><start>879</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B39"><titleInfo><title>Arch Dis Child</title></titleInfo><note>Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995; 73: 117–20</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>73</number></detail><extent unit="pages"><start>117</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B40"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J 1997; 16: 43–7</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>43</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B41"><titleInfo><title>JAMA</title></titleInfo><note>Turner RB, Wecker MT, Pohl G et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 1999; 281: 1797–804</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>281</number></detail><extent unit="pages"><start>1797</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B42"><titleInfo><title>Epidemiol Infect</title></titleInfo><note>Hanratty B, Holt T, Duffell E et al. UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiol Infect 2000; 125: 377–83</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>377</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B43"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Quiambao BP, Gatchalian SR, Halonen P et al. Coinfection is common in measles-associated pneumonia. Pediatr Infect Dis J 1998; 17: 89–93</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>89</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B44"><titleInfo><title>Rev Infect Dis</title></titleInfo><note>Kaschula RO, Druker J, Kipps A. Late morphologic consequences of measles: a lethal and debilitating lung disease among the poor. Rev Infect Dis 1983; 5: 395–404</note><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>395</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B45"><titleInfo><title>Cochrane Review</title></titleInfo><note>Shann F, D'Souza RM, D'Souza R. Antibiotics for preventing pneumonia in children with measles (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software</note></relatedItem><relatedItem type="references" displayLabel="B46"><titleInfo><title>Cochrane Review</title></titleInfo><note>D'Souza RM, D'Souza R. Vitamin A for treating measles in children (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software</note></relatedItem><relatedItem type="references" displayLabel="B47"><titleInfo><title>N Engl J Med</title></titleInfo><note>Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 1990; 323: 160–4</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>160</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B48"><titleInfo><title>BMJ</title></titleInfo><note>Aaby P, Samb B, Simondon F, Seck AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995; 311: 481–5</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>311</number></detail><extent unit="pages"><start>481</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B49"><titleInfo><title>Scand J Infect Dis</title></titleInfo><note>Heurlin N, Brattstrom C, Tyden G, Ehrnst A, Andersson J. Cytomegalovirus the predominant cause of pneumonia in renal transplant patients. A two-year study of pneumonia in renal transplant recipients with evaluation of fiberoptic bronchoscopy. Scand J Infect Dis 1989; 21: 245–53</note><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>245</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B50"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Winnie GB, Cowan RG. Association of Epstein-Barr virus infection and pulmonary exacerbations in patients with cystic fibrosis. Pediatr Infect Dis J 1992; 11: 722–6</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>722</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B51"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992; 11: 441–5</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>441</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B52"><titleInfo><title>Am J Dis Child</title></titleInfo><note>Morgan ER, Smalley LA. Varicella in immunocompromised children. Incidence of abdominal pain and organ involvement. Am J Dis Child 1983; 137: 883–5</note><part><date>1983</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>883</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B53"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>MacDonald NE, Morris RF, Beaudry PH. Varicella in children with cystic fibrosis. Pediatr Infect Dis J 1987; 6: 414–6</note><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>414</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B54"><titleInfo><title>Clin Infect Dis</title></titleInfo><note>Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17 (Suppl 1): S37–46</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>17 (Suppl 1)</number></detail><extent unit="pages"><start>S37</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B55"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Wang EE, Frayha H, Watts J et al. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 1988; 7: 547–51</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>547</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B56"><titleInfo><title>Arch Dis Child Suppl</title></titleInfo><note>Hannaford K, Todd DA, Jeffery H, John E, Blyth K, Gilbert GL. Role of Ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Suppl 1999; 81: F162–7</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>F162</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B57"><titleInfo><title>Pediatr Pulmonol</title></titleInfo><note>Ollikainen J. Perinatal Ureaplasma urealyticum infection increases the need for hospital treatment during the first year of life in preterm infants. Pediatr Pulmonol 2000; 30: 402–5</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>402</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B58"><titleInfo><title>Ann Allerg</title></titleInfo><note>Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allerg 1993; 70: 23–5</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>23</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B59"><titleInfo><title>Acta Paediatr Scand</title></titleInfo><note>Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma – possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981; 70: 623–8</note><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>623</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B60"><titleInfo><title>Clin Pediatr</title></titleInfo><note>Orlicek SL, Walker MS, Kuhls TL. Severe mycoplasma pneumonia in young children with Down syndrome. Clin Pediatr 1992; 31: 409–12</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>409</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B61"><titleInfo><title>Mycoplasma pneumoniae</title></titleInfo><note>Baum SG. Mycoplasma pneumoniae and atypical pneumonia. In: Mandell GL, Bennett JE, Dolin R. (eds) Principles and Practice of Infectious Disease. Edinburgh: Churchill Livingstone, 2000</note></relatedItem><relatedItem type="references" displayLabel="B62"><titleInfo><title>J Clin Microbiol</title></titleInfo><note>Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol 1999; 37: 14–7</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>14</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B63"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><note>Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14: 471–7</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>471</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B64"><titleInfo><title>Acta Paediatr</title></titleInfo><note>Jonsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr 1998; 87: 1079–84</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>1079</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B65"><titleInfo><title>JAMA</title></titleInfo><note>Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255: 3374–7</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>255</number></detail><extent unit="pages"><start>3374</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B66"><titleInfo><title>Pediatrics</title></titleInfo><note>Brasfield DM, Stagno S, Whitley RJ, Cloud G, Cassell G, Tiller RE. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics 1987; 79: 76–83</note><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>76</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B67"><titleInfo><title>Scand J Infect Dis</title></titleInfo><note>Heiskanen-Kosma T, Korppi M, Laurila A, Jokinen C, Kleemola M, Saikku P. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. Scand J Infect Dis 1999; 31: 255–9</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>255</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B68"><titleInfo><title>Lancet</title></titleInfo><note>Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983–6</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>983</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B69"><titleInfo><title>J Infect Dis</title></titleInfo><note>Campbell LA, O'Brien ER, Cappuccio AL et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585–8</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>172</number></detail><extent unit="pages"><start>585</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B70"><titleInfo><title>J Hosp Infect</title></titleInfo><note>Verissimo A, Vesey G, Rocha GM et al. A hot water supply as the source of Legionella pneumophila in incubators of a neonatology unit. J Hosp Infect 1990; 15: 255–63</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>255</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B71"><titleInfo><title>Boll Istituto Sieroterapico Milanese</title></titleInfo><note>Maggiolo F, Sampietro C, Maladorno D, Torre D. Prevalence of antibodies to Legionella pneumophila and micdadei in hospitalized children. Boll Istituto Sieroterapico Milanese 1986; 65: 153–6</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>153</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B72"><titleInfo><title>Arch Dis Child</title></titleInfo><note>Beer S, Boldur I, Kazak R, Avidan S, Kannai Y. Serum antibodies to Legionella agents in bronchial asthma. Arch Dis Child 1985; 60: 225–30</note><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><extent unit="pages"><start>225</start></extent></part></relatedItem><relatedItem type="references" displayLabel="B73"><titleInfo><title>Microbiol Immunol</title></titleInfo><note>Nagaoka H, Akiyama M, Sugieda M et al. Isolation of Coxiella burnetii from children with influenza-like symptoms in Japan. Microbiol Immunol 1996; 40: 147–51</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>147</start></extent></part></relatedItem><identifier type="istex">D1760D2B4DDDD007126547C486024CAD3BD7F5FF</identifier><identifier type="ark">ark:/67375/HXZ-NK88TQ8T-7</identifier><identifier type="DOI">10.1093/bmb/61.1.247</identifier><identifier type="PII">0007-1420</identifier><identifier type="local">247</identifier><accessCondition type="use and reproduction" contentType="copyright">© Oxford University Press. All rights reserved.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</recordContentSource><recordOrigin>Converted from (version 1.2.0) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-12-09</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-NK88TQ8T-7/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001529 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001529 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:D1760D2B4DDDD007126547C486024CAD3BD7F5FF
|texte= Pneumonia due to viral and atypical organisms and their sequelae
}}
| This area was generated with Dilib version V0.6.33. |  |